Checkmate Pharmaceuticals, Inc.·4

Jun 17, 4:33 PM ET

Krieg Arthur M 4

4 · Checkmate Pharmaceuticals, Inc. · Filed Jun 17, 2021

Insider Transaction Report

Form 4
Period: 2021-06-16
Krieg Arthur M
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2021-06-16$6.18/sh+3,578$22,112808,510 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions, at prices ranging from $6.17 to $6.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION